PAM
ARCT icon

Panagora Asset Management’s Arcturus Therapeutics ARCT Stock Holding History

Panagora Asset Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-34,768
Closed -$213K – 1169
2025
Q4 		$213K Buy
+34,768
New +$375K ﹤0.01% 1104
2021
Q2 		– Sell
-15,951
Closed -$659K – 2768
2021
Q1 		$659K Buy
15,951
+9,321
+141% +$556K ﹤0.01% 1205
2020
Q4 		$288K Sell
6,630
-6,294
-49% -$426K ﹤0.01% 1439
2020
Q3 		$554K Sell
12,924
-8,023
-38% -$398K ﹤0.01% 1122
2020
Q2 		$979K Buy
20,947
+20,318
+3,230% +$700K 0.01% 943
2020
Q1 		$9K Hold
629
– – ﹤0.01% 2149
2019
Q4 		$7K Hold
629
– – ﹤0.01% 2181
2019
Q3 		$6K Buy
+629
New +$6.8K ﹤0.01% 2244
2017
Q4 		– Sell
-33,324
Closed -$236K – 2299
2017
Q3 		$236K Sell
33,324
-31,216
-48% -$235K ﹤0.01% 1616
2017
Q2 		$506K Buy
64,540
+37,886
+142% +$305K ﹤0.01% 1347
2017
Q1 		$213K Buy
+26,654
New +$247K ﹤0.01% 1638
2015
Q4 		– Sell
-1,675
Closed -$71K – 2302
2015
Q3 		$71K Buy
+1,675
New +$88.1K ﹤0.01% 1901

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Panagora Asset Management's ARCT Position: Q1 2026 in Review

Panagora Asset Management sold out of Arcturus Therapeutics (ARCT) in Q1 2026, closing a stake of 34,768 shares — an estimated $213K sold.

Panagora Asset Management first reported a position in ARCT in Q3 2015 and held it in 12 quarters. The position peaked at $979K in Q2 2020. 124 funds tracked by Wall St. Rank hold ARCT as of Q1 2026.

  • Panagora Asset Management reported no remaining Arcturus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Panagora Asset Management sold 34,768 Arcturus Therapeutics shares in Q1 2026, an estimated $213K.
  • Panagora Asset Management first reported a position in Arcturus Therapeutics in Q3 2015 and held it in 12 quarters.
  • Panagora Asset Management's Arcturus Therapeutics position peaked at $979K in Q2 2020.
  • 124 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.